Alterity Therapeutics (ATHE) Equity Ratio (2017 - 2018)

Alterity Therapeutics (ATHE) has 2 years of Equity Ratio data on record, last reported at 0.86 in Q2 2018.

  • For Q2 2018, Equity Ratio fell 8.36% year-over-year to 0.86; the TTM value through Jun 2018 reached 0.86, changed N/A, while the annual FY2018 figure was 0.86, 8.36% down from the prior year.
  • Equity Ratio reached 0.86 in Q2 2018 per ATHE's latest filing, down from 0.94 in the prior quarter.
  • Across five years, Equity Ratio topped out at 0.94 in Q2 2017 and bottomed at 0.86 in Q2 2018.